IL22 and colitis: Conversely, IL-22−/− mice infected with C. rodentium experience more severe colitis than WT mice and show no benefit from butyrate supplementation, thus suggesting a crucial role for IL-22 as a critical mediator acting downstream butyrate signaling pathway [56].